title: Carcinoid crisis induced by repeated abdominal examination.
authors.forename: K
authors.initials: K
authors.lastname: Morrisroe
authors.forename: I-W
authors.initials: IW
authors.lastname: Sim
authors.forename: K
authors.initials: K
authors.lastname: McLachlan
authors.forename: W J
authors.initials: WJ
authors.lastname: Inder
mesh_terms: D000005:Abdomen; D000410:Alanine Transaminase / Q000097:blood; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D002276:Carcinoid Tumor / Q000188:drug therapy / Q000378:metabolism / Q000451:nursing / Q000556:secondary; D003907:Dexamethasone / Q000627:therapeutic use; D018450:Disease Progression; D004501:Education, Medical / Q000379:methods; D005440:Fluid Therapy; D006801:Humans; D007049:Iatrogenic Disease; D007262:Infusions, Intravenous; D019934:International Normalized Ratio; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D010456:Peptides, Cyclic / Q000627:therapeutic use; D010808:Physical Examination / Q000009:adverse effects*; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D003907:Dexamethasone; D002097:C-Reactive Protein; D000410:Alanine Transaminase; D015282:Octreotide